Stay updated on Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial page.

Latest updates to the Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange Detected- Added Contacts/Locations and updated Study Status in the record history to reflect updated site information and current recruitment status. - There is a deletion recorded on 2025-09-22 in the history.SummaryDifference0.3%

- Check22 days agoChange DetectedAdded site revision entry: Revision: v3.3.2 and removed Revision: v3.2.0 from the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedRemoval of a government funding lapse notice; core trial data and status information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check43 days agoChange DetectedA new version entry was added to the Record History, showing updated Study Status and Contacts/Locations.SummaryDifference0.1%

- Check72 days agoChange DetectedCore content updated to inform users about funding-related operating status and current NIH Clinical Center openness; version updated from v3.1.0 to v3.2.0.SummaryDifference10%

- Check79 days agoChange DetectedPage update adds a new study status/contacts/locations section and bumps the revision to v3.1.0, while removing the old v3.0.2 tag.SummaryDifference1%

Stay in the know with updates to Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial page.